3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Prostatic Neoplasms
11
Precancerous Conditions
4
Urinary Bladder Neoplasms
3
Colonic Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Rectal Neoplasms
2
Male Urogenital Diseases
2
Colorectal Neoplasms
2
Adenomatous Polyps
2
Thyroid Nodule
1
Prevention of Colorectal Cancer
1
Polyps
1
Ovarian Neoplasms
1
Non-melanoma Skin Cancer
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Inflammation
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Risk
1
Arsenic Poisoning
1
Interventions
Diclofenac
2
whole grape extract
1
Vitamin E
1
Tomography, Optical Coherence
1
Selenium
1
Negative-Pressure Wound Therapy
1
Eflornithine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Non-melanoma Skin Cancer
×
Selenium
×
Clear all
NCT00392561
2023-04-26
BEST
University of Chicago
Phase NA
Completed
7,000 enrolled